Massive Bio, NeoGenomics Collaborate on AI-Driven Oncology Clinical Trial Matching

Under the partnership, NeoGenomics, a Fort Myers, Florida-based cancer genetic testing and contract research organization, will screen and identify patients with biomarkers that might qualify them for clinical trials. New York-based Massive Bio will then assist treating physicians with obtaining patient consent and additional testing to support the enrollment process.

Source: https://www.genomeweb.com/business-news/massive-bio-neogenomics-collaborate-ai-driven-oncology-clinical-trial-matching#.ZBxWqXbMKUk